Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Mike Jafari who wrote (7086)	8/31/1998 2:51:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Two possible reasons: 1. Perhaps some still think MacKinzie survey meant something and are buying. 2. Perhaps buying generated by belief in earl halt of Meningococcemia trial. While these are logical they probably are not the reasons. Unless the DSMB recommends early halt there will not be an early halt. I do not understand how one can predict what the DSMB will do. Perhaps someone with enough ability to obtain data has followed up on individual cases of Meningococcemia at St. Marys in London and with knowledge of the total death rate of those patients believes they can predict the DSMB decision. At any rate the price action will tell us something if buying continues even in the face of no early halt, then other factors are at work. Any other ideas?